ARWR

ARROWHEAD PHARMACEUTICALS INC

Healthcare | Mid Cap

-$0.93

EPS Forecast

$48.44

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2025-09-30
PRTAProthena Corp Public Ltd CoMDGLMadrigal Pharmaceuticals IncHRMYHarmony Biosciences Holdings IncINSMInsmed IncMNKDMannkind CorpRCUSArcus Biosciences IncXNCRXencor IncCYTKCytokinetics IncENTAEnanta Pharmaceuticals IncTBPHTheravance Biopharma Inc